Table 1

Trends of diabetic foot complications among patients with T2D

Year20072008200920102011201220132014P for trend
Patients with DFC23 06826 03927 36828 72929 77030 00730 33230 783
T2D population1 115 5561 192 0041 269 4961 339 2231 404 4741 472 4481 535 6131 556 988
 DFCs prevalence, %
 (95% CI)
2.07
(2.04 to 2.09)
2.18
(2.16 to 2.21)
2.16
(2.13 to 2.18)
2.15
(2.12 to 2.17)
2.12
(2.10 to 2.14)
2.04
(2.02 to 2.06)
1.98
(1.95 to 2.00)
1.98
(1.96 to 2.00)
0.024
 Cost*: DFCs/T2D
 ratio (%)
8.8/2.7
330
8.8/2.7
325
9.1/2.7
335
9.1/2.7
338
9.2/2.7
336
9.0/2.7
337
8.9/2.7
328
8.5/2.6
320
 0.659
LEAs (per 1000 subjects with T2D)2.852.912.722.592.682.292.072.060.001
 Minor LEA1.251.331.291.241.331.141.091.090.019
 Major LEA1.601.571.431.351.351.150.980.98<0.001
 Major/total LEAs (%)56.254.152.752.350.550.347.347.4<0.001
  • *Cost unit=US$1000 per one person-years.

  • DFC, diabetic foot complication; LEA, lower extremity amputations; T2D, type 2 diabetes.